Therapeutic vaccines for prostate cancer: a review of clinical data.

Abstract

Prostate cancer is the most common, non-cutaneous cancer and the second leading cause of cancer death among men in the US. A greater understanding of basic immunological principles has led to the development of a variety of new techniques, which in turn has led to advances in the field of prostate cancer vaccines. This review will discuss the rationale for… (More)

Topics

Cite this paper

@article{Arlen2005TherapeuticVF, title={Therapeutic vaccines for prostate cancer: a review of clinical data.}, author={Philip M. Arlen and James L. Gulley}, journal={Current opinion in investigational drugs}, year={2005}, volume={6 6}, pages={592-6} }